Rivista 13.13

Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.

Autori: Morano A, Fattouch J, Albini M, Casciato S, Fanella M, Basili LM, Viganò A, Manfredi M, Giallonardo AT, Di Bonaventura C.

Data: 2018

Ambito di interesse: Epilessia

Rivista: J Neurol Sci. 2018 Jul 15;390:67-74

Potrebbero interessarti anche:

Rivista 7,4

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Autori: ranieri r et al

Data: 17 apr 2023

Ambito di interesse: infettivologico/sanità penit

Rivista: infection

Leggi dettagli

Rivista 3.028

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy.

Autori: Romigi A, Vitrani G, Lo Giudice T, Centonze D, Franco V.

Data: 2018

Ambito di interesse: Neurologia narcolessia

Rivista: Drug Des Devel Ther

Leggi dettagli

Rivista

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant

Autori: Marchesi F, Capria S, Giannarelli D, Trisolini SM, Ansuinelli M, Caputo MD, Serrao A, Gumenyuk S, Renzi D, Pupo L, Palombi F, Provenzano I, Di Rocco A, Pisani F, Romano A, Spadea A,Canfora M, Cantonetti M, Mengarelli A

Data: 2018

Ambito di interesse: Ematologia/Medicina Trasfusionale

Rivista: Bone Marrow Transplant.2018 Aug; PMID:26442854

Leggi dettagli

Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.

Potrebbero interessarti anche:

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel.

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy.

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant

Cosa fare per